Crossmark

Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection

Crossref DOI link: https://doi.org/10.1007/s00330-022-08570-4

Published Online: 2022-02-10

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toyoda, Hidenori https://orcid.org/0000-0002-1652-6168
Yasuda, Satoshi

Shiota, Shohei

Sone, Yasuhiro

Maeda, Atsuyuki

Kaneoka, Yuji

Kumada, Takashi

Tanaka, Junko
Funding

Funding for this research was provided by:

Ministry of Health, Labour and Welfare
License Information

Text and Data Mining valid from 2022-02-10

Version of Record valid from 2022-02-10
More Information

Article History

Received: 7 October 2021

Revised: 8 December 2021

Accepted: 7 January 2022

First Online: 10 February 2022

Declarations

:

: The scientific guarantor of this publication is Hidenori Toyoda.

: Hidenori Toyoda reports a speaker honorarium from AbbVie, MSD, and Bayer, and Takashi Kumada reports a speaker honorarium from AbbVie, Bristol-Meyers Squibb, and Gilead Sciences. Other authors declare that they have no conflict of interest.

: No complex statistical methods were necessary for this paper.

: Written informed consent was waived by the institutional review board.

: Institutional review board approval was obtained.

: • retrospective study of prospectively observed cohort• observational study• performed at one institution

Document is current

Any future updates will be listed below